OMAKASE CONSULTING is a strategic Value & Market Access consulting firm with an European Outreach and specialised in Spanish Pricing & Reimbursement and Regional & Hospital Market Access.
We offer strategic support to companies during the drugs’ full lifecycle: from the regulatory process, including the Therapeutic Positioning Report (TPR) development to P&R submission, negotiation and approval, and Market Access at regional and hospital level. We do so by collaborating with relevant stakeholders, scientific societies and patients associations to ensure a successful Pricing and Market Access for innovative drugs in Spain.
We work in partnership with pharmaceutical & biotech companies that seek reimbursement & market access for a health technology in Spain, focusing on innovative medicines diagnostic and specialised in ORPHAN DRUGS & ATMPs.